Target Treatment with StrataDx's

Employer
Strata
Location
United States
Posted
Jan 01, 2019
Closes
Jan 31, 2019
Profession
Physician
Specialty
Dermatology

Preparing for a Career Break

Target Treatment with StrataDx's Onychodystrophy DNA Test

The answers you need to guide your nail infection treatment

Targeted Technology Knowing the genus/species of the causative agent allows for targeted therapy. 99.9% Analytical Specificity

Accurate Correlates highly with gold standard histology, while providing identification of genus/species. 86% Clinical Sensitivity

Timely Rapid results mean the right treatment, right away 48-72 hrs. Turnaround Time

Cost-Effective Quick identification of genus/species supports informed treatment decisions that can more quickly lead to effective outcomes. Effective Outcomes

Required Many payors require precise identification of fungal species for preauthorization of anti-fungal Rx.

Payor Required Covered StrataDx's onychodystrophy DNA test is covered by Medicare and most insurance plans Payer

Learn  more: StrataDx.com  Call Now: 800-325-PATH (7284)

Similar jobs

Similar jobs